Professor Basil Sharrack

MD, PhD, FRCP

Neuroscience, School of Medicine and Population Health

Consultant Neurologist

Honorary Professor of Clinical Neurology

b.sharrack@sheffield.ac.uk
+44 114 271 3909
+44 114 271 3909 (NHS Secretary: Carly Barber)
+44 114 2713684 (fax)
ºù«Ӱҵ Institute for Translational Neuroscience (SITraN)

Full contact details

Professor Basil Sharrack
Neuroscience, School of Medicine and Population Health
ºù«Ӱҵ Institute for Translational Neuroscience (SITraN)
385a Glossop Road
ºù«Ӱҵ
S10 2HQ
Profile
  • Consultant Neurologist, Department of Neurosciences, Royal Hallamshire Hospital, ºù«Ӱҵ (January 1999 – Present time)
  • Specialist Registrar, the National Hospital for Neurology and Neurosurgery, Queen Square, UCL, London (Feb 98 - Dec 98)
  • Specialist Registrar, Department of Neurology, Chelsea & Westminster Hospital, Imperial Collage, London (Sept 97 - Jan 98)
  • Clinical Research Fellow, United Medical and Dental Schools, Guy’s Hospital, King’s College, London (Jun 94 - Aug 97)
  • Clinical Lecturer, Department of Neurology, Aleppo University Hospital, Aleppo University, Aleppo, Syria (Nov 93 - May 94)
  • Career Registrar, Department of Clinical Neurology, Royal Hallamshire Hospital, ºù«Ӱҵ (Feb 91 - Oct 93)
Research interests

Principal academic areas of interest

  • Neuro inflammation and degeneration with reference to multiple sclerosis
  • Therapeutic clinical trials in multiple sclerosis
  • Autologous Haematopoietic stem cell transplantation in multiple sclerosis
  • Cognitive rehabilitation in multiples sclerosis
  • Idiopathic intracranial hypertension

Academic Activity

  • Over 90 peer reviewed original articles (5924 citations; H-Index 30).
  • Over £8,000,000 in grants and income from commercial clinical trials.
  • Eight PhDs and one MD have been awarded, five ongoing PhDs projects.
  • Leading UK role in the design and conduct of clinical trials in multiple sclerosis (includes: first gene therapy trial at the ºù«Ӱҵ Teaching Hospitals NSH Foundation Trust and the first phase III Autologous Haematopoietic Stem Cell Transplantation treatment in patients with multiple sclerosis).
Grants
  • Multiple Sclerosis Society
  • National Institute of Health Research (NIHR)
  • Biogen
Professional activities and memberships
  • Director of the ºù«Ӱҵ MS Research Clinic
  • Chair of the ºù«Ӱҵ Research Ethics Committee
  • Member of the EBMT Autoimmune Diseases Working Party

Links

Basil Sharrack NHS email  NHS Secretary: Carly Barber email